Journal of Critical Care· 2026Q1
Protocolised analgosedation in mechanically ventilated adult patients: A scoping review
- 0citations
- Q1SCImago
- 2026year
Short summary
A scoping review of 81 studies found few recent protocols (2019-2026) for mechanically ventilated adults, including ECMO patients, incorporated propofol, dexmedetomidine, multi-modal analgesia, or delirium assessment.
AI-generated from the title and abstract; the full text is not read.
Key points
- 81 studies were included in the scoping review of analgosedation protocols for mechanically ventilated adults.
- Few protocols published between 2019-2026 incorporated propofol, dexmedetomidine, multi-modal analgesia, or delirium assessment.
- No studies specifically addressed analgosedation protocols for ECMO patients.
- Insufficient protocol detail (63% of studies) and staff fear of adverse effects were major implementation barriers.
- Easily accessible protocol formats were the most frequently reported facilitator (31% of studies).
AI-generated from the title and abstract; the full text is not read.
Abstract
PURPOSE: Our objectives were to assess structure and content of analgosedation protocols used for mechanically ventilated adult patients, including those receiving extracorporeal membrane oxygenation (ECMO), against current international sedation guidelines, and to explore reported barriers and facilitators to their implementation. MATERIALS AND METHODS: Scoping review searching five databases (December 1999 to September 2026). We included all study types reporting on analgosedation protocol structure and content, and/or implementation barriers/facilitators. Two authors independently screened citations, extracted data, and coded reported barriers and facilitators using the Theoretical Domains Framework. RESULTS: We screened 18,457 citations with 81 studies meeting inclusion criteria. Of these, 35 (43%) were observational studies, 27 (33%) non-randomised interventional studies, and 19 (23%) randomised controlled trials. Few studies published between 2019 and 2026 included propofol or dexmedetomidine, multi-modal analgesia and delirium assessment in analgosedation protocols, and no studies in ECMO patients. The most frequently reported structure and content of protocol was use of a sedation score (77%), recommending opioid and sedative drugs (74%), and setting a daily target sedation score (65%). Most reported barrier was a protocol insufficiently detailed to cover the breadth of patient needs, reported in 12 (63%) studies. The most frequently reported facilitator was availability of the analgosedation protocol in an easily accessible format, reported in four (31%) studies. CONCLUSIONS: Easy to follow protocols sufficiently detailed to cover patient need from a heterogenous ICU population are considerations to successful implementation. Healthcare staff fear of adverse effects is a potential barrier to adoption of protocolised analgosedation.
The authors' abstract, as published at the source. Journal of Critical Care, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Critical Care and Intensive Care Medicine
Critical Care and Intensive Care MedicineMedicine